These guidelines address the diagnosis and management of atherosclerotic, aneurysmal,
and thromboembolic peripheral arterial diseases (PADs). The clinical manifestations of PAD …

Lower extremity peripheral arterial disease (PAD) affects approximately 10% of the
American population, with 30% to 40% of these patients presenting with claudication …

Background—Several individual pharmacological agents, such as antiplatelet drugs, β-
blockers, ACE inhibitors, and lipid-lowering agents, have proven efficacy in reducing …

São apresentadas, nessa separata, as principais orientações sobre a atenção às
complicações do pé diabético. A neuropatia, com suas diversas apresentações que …

Objectives: We sought to assess the impact of the American College of Cardiology's
Guidelines Applied in Practice (GAP) project for acute myocardial infarction (AMI) care …

Aims The purpose of the Euro Heart Survey Programme of the European Society of
Cardiology is to evaluate to which extent clinical practice endorses existing guidelines as …

Aims The aim was to assess trends in peripheral arterial disease (PAD) incidence and
mortality rates in European Union (15+) countries between 1990 and 2017. Methods and …

OBJECTIVES: Patients who require infrainguinal revascularization for critical limb ischemia
(CLI) are at elevated risk for cardiovascular events. The PREVENT III study was a …

OBJECTIVE: Evidence suggesting a beneficial effect of cardioprotective medications in
patients with lower extremity atherosclerosis derives largely from secondary prevention …

INTRODUCTION: Established American Heart Association guidelines recommend the use of
statin drugs, angiotensin converting enzyme (ACE) inhibitors, and antiplatelet agents in …